newsfilter
← Latest News
GlobeNewswire·

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that on November 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock